An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)
作者
Thomas J. Smith,Patrick J. Coyne,Peter S. Staats,Timothy Ray Deer,Lisa Jo Stearns,Richard L Rauck,Richard L. Boortz-Marx,Eric Buchser,Eva Catalá,David A. Bryce,Michael J. Cousins,George E. Pool
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2005-04-08卷期号:16 (5): 825-833被引量:190